GLP/GCP-compliant contract research organisation QPS has recently installed the latest 5.7.8 version of Debra, LabLogic's LIMS for absorption, distribution, metabolism and excretion studies (ADME), at its Newark, Delaware facility.
Ben Chien, PHD, QPS chairman, president and CEO, said: ‘Studies determining ADME patterns in laboratory animals and humans are an integral part of our drug metabolism and pharmacokinetic services and, as a quality initiative, we have been actively integrating radio-labelled mass balance/excretion and tissue distribution by Quantitative Whole-Body Autoradiography under one study protocol.
‘This allows us to start on the companion metabolite profiling and identification studies in a shorter time frame. The addition of Debra will increase our competitive advantage and allow us to report high-quality data to our sponsors even more quickly.’
Huw Loaring, systems director at LabLogic, added: ‘Contract research organisations (CROs) are seeing big returns from the time savings achieved using Debra for their ADME studies, especially in terms of reporting and data checking. Increasingly, many pharmaceutical customers are using turnkey ADME solution providers like QPS – not just for their in-vivo studies, but also for radiochromatography on their samples and the ensuing determination of key metabolites.’
